PM360 9th Annual ELITE 100 Open for Submissions
06 Dec 2022
Now Accepting Entries Recognizing the Most Influential People in Healthcare
NEW YORK, Dec. 6, 2022 /PRNewswire/ --PM360, a leading healthcare and life sciences marketing industry trade magazine, will once again honor the PM360 ELITE:
Exceptional •
Leaders •
Entrepreneurs.
For nine years, the PM360 ELITE 100 has served as an illustrious list of the top difference-makers across the healthcare and life sciences industries. Nominees are judged based on their career achievements, the impact their work has had on the industry, or their vision for transforming the industry. To bring these leaders to the forefront, the magazine is seeking submissions in 20 categories:
Transformational Leaders
Leaders of the Future
Creative Directors
Entrepreneurs
Sales MVPs
Strategists
Disrupters
Launch Experts
Digital Crusaders
PR Gurus
Talent Acquisition Leaders
Philanthropic Heroes
To learn more about all of the categories or to start your submissions, visit www.pm360online.com/elite. The initial deadline for submissions is February 24, 2023. PM360 will then continue to accept entries until March 17, but anything after Feb. 24 will be subject to a $195 late fee.
Anyone from a manufacturer (pharma, medical device, diagnostics, biotech, or specialty), advertising agency, or any company serving the life sciences industry is eligible to enter in any of the categories. Nominees can be submitted in multiple categories. Entries will be judged by the PM360 editorial staff.
The PM360 ELITE winners will be featured in the publication's May 2023 issue and later celebrated at an event held in the summer of 2023.
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Contact:
Andrew Matthius
Senior Editor
[email protected]
SOURCE PM360
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.